In June 2026, our team exhibited at the ISBT in Kuala Lumpur—an international gathering for professionals, companies, and partners in the field of transfusion medicine and related areas.
ISBT 2026 Kuala Lumpur
For us, the event was a valuable opportunity to present our Jetrail® system to an international audience and to deepen our direct dialogue with customers, sales partners, and prospective clients. “Our customers are transfusion physicians and senior staff at blood banks. It was wonderful to meet our contacts in person and learn firsthand about new projects and plans in their professional environments,” says Alexander Höfinger, CEO and co-founder of On point medicals. It was also a great opportunity to discuss new insights and developments not only regarding our blood irradiation indicators but, above all, regarding the production of serum eye drops.
The focus of our trade show presence was Jetrail®: our innovative system, which impressed visitors with its ease of use and clear functionality. It was particularly gratifying that interested parties were able to try out the system for themselves right there on the spot. This quickly demonstrated how intuitively Jetrail® works and how straightforward the system is to explain, understand, and operate.
“Nothing compares to meeting customers in person and getting updates on-site.”
„
A particular highlight was the numerous visits to our booth by our sales partners and customers. The face-to-face conversations, the positive feedback, and the keen interest in Jetrail® have once again shown us how important international events like the ISBT are for professional exchange and the further development of innovative solutions.
Participating in Kuala Lumpur was not only a platform for us to showcase our products but also a strong statement of our international focus. We’re delighted with the many new ideas, valuable contacts, and exciting conversations we’re taking away from the ISBT.
Our conclusion: Jetrail® is generating significant international interest—and we look forward to continuing on this path together with our partners and customers.
The next ISBT meetings will be regional conferences and will take place in Rotterdam and Doha in 2027.
Interesting posts
In June 2026, we exhibited at ISBT in Kuala Lumpur—an international gathering for professionals, companies, and partners in the field of transfusion medicine and related areas—click here for the trade show report.
The safe use of irradiated blood products begins with proper monitoring. A training video from KABEG Klinikum Klagenfurt shows how physicians can use the irradiation indicator to reliably check whether blood products have been irradiated correctly before transfusion.
Blood irradiation is an important part of transfusion medicine for preventing TA-GvHD disease. A training video from KABEG Klinikum Klagenfurt provides practical insight into the background, procedures, and quality requirements of blood irradiation.
Both autologous and allogeneic serum eye drops show positive effects in patients with severe ocular surface diseases. But what are the differences between these forms of therapy?
We’re back from an inspiring week at ISBT Milan 2025, where we had the opportunity to connect with leading voices in transfusion medicine from around the world.
Autologous serum eye drops are obtained from the patient's own blood and represent an individualized and highly effective form of treatment for patients with severe eye conditions.
Serum Eye Drops (SED) are highly effective in the treatment of patients suffering from dry eye disease, among other things. You can find out where and how to obtain serum eye drops in Austria here.
On point medicals has won the 2024 Innovations- and Research Award of the Federal State of Carinthia.
Dry eye disease (DED) is a prevalent and often underestimated ocular condition that affects millions of people worldwide. Find out more about causes, symptoms and treatment options.
Serum Eye Drops (SED) are similar to normal tears and show a high efficacy in therapy with patients suffering from severe ocular surface problems, such as Dry Eye Disease. Learn more about this widely unknown blood-derived therapy.
